Covid-19 non-invasive rapid detection system, prototype screening devices to be used for data gathering purposes in order to evaluate the effectiveness of the technology.

Ended Definitive Contract Awarded Last action

Contract number
W911SR21C0008
Awardee
Awarding agency
Obligated
$392,500

Award facts

Opportunity
Contract value 100% obligated
$392,500.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Funding agency
Joint PEO Chemical and Biological Defense Acquisition Support Center, Department of Defense
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
1701 Kenly Ave #134, Lackland AFB, TX 78236, USA
National interest action
Coronavirus COVID-19

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00005 · Government furnished property (GFP) transfer modification of five(5) covid-19 prototype screening devices to a new, cooperative research and development… $0
Funding Only Action P00004 · Deobligation of excess funds modification (training and testing events)for covid-19 prototype screening devices. -$9,850
Change Order P00003 · Fund realingment and contractor acquired property transfer for covid-19 prototype screening devices $0
Change Order P00002 · Change order modification to revise the delivery date and one-day training event for covid-19 prototype screening devices $0
Other Administrative Action P00001 · Administrative modification to incorporate ship to information for covid-19 prototype screening devices $0
Original award $402,350

About this award

This $392,500 firm fixed price contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Worlds Enterprises Inc. to supply prototype COVID-19 non-invasive rapid detection system screening devices. The devices will be used by the Army to gather data and evaluate the effectiveness of the technology in responding to the coronavirus pandemic. Performance will take place in Lackland Air Force Base, Texas from November 2020 through July 2021. The original solicitation sought proposals for up to 500 million FDA-approved combination needle and syringe units or individual sterile needles and syringes to supply the Department of Health and Human Services' Assistant Secretary for Preparedness and Response and Biomedical Advanced Research and Development Authority in response to COVID-19, with no set-aside designation.

Quick answers

Who was awarded contract W911SR21C0008?

W911SR21C0008 was awarded to Worlds Enterprises Inc. by ACC Aberdeen Proving Ground (Army Contracting Command) on November 13, 2020.

How much is contract W911SR21C0008 worth?

The government has obligated $392,500 on W911SR21C0008.

Which agency awarded contract W911SR21C0008?

ACC Aberdeen Proving Ground (Army Contracting Command) awarded W911SR21C0008, with funding from Joint PEO Chemical and Biological Defense (Acquisition Support Center).

Was contract W911SR21C0008 competed?

The extent of competition for W911SR21C0008 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award